Latest Breaking News On - Daina graybosch - Page 6 : comparemela.com

ACLX Stock Breaks Out After Inking A $285 Million Deal With Gilead s Kite

ACLX Stock Breaks Out After Inking A $285 Million Deal With Gilead s Kite
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Daina grayboschGilead scienceChief executive rami elghandourHunting downRelative strength rating

Innate Pharma S A (NASDAQ:IPHA) Q3 2023 Earnings Call Transcript

Operator: Thank you for standing by, and welcome to the Innate Pharma Third Quarter 2023 Financial Results and Business Update.

San diegoUnited statesMondher mahjoubiHenry wheelerYigal nochomovitzSonia quaratinoFrederic lombardCarly kenselaarDaina grayboschRabib chaudhuryBiggest beauty companiesClothing companiesCall transcript novemberInnate pharma third quarterInvestor relationsChief executive

ACLX Stock Breaks Out After Inking A $285 Million Deal With Gilead s Kite

Daina grayboschGilead scienceChief executive rami elghandourHunting downRelative strength rating

Gilead s $285M Confidence Vote for Next-Gen Cancer Med & New Cell Therapy Tech

Gilead Sciences is increasing its stake in partner Arcellx and expanding the cell therapy alliance the companies started in 2022. The deal expands the lead partnered program to more cancers and gives Gilead a chance at another Arcellx cell therapy candidate made with different technology.

United statesSan diegoFoster cityDaina grayboschCindy perettieAmerican society of hematologyBristol myers squibbGilead sciencesMyers squibbLegend biotechLeerink partnersAmerican societyWeight lossMedical devicesHealthcare innovationMedcity news

Fate Therapeutics, Inc (NASDAQ:FATE) Q3 2023 Earnings Call Transcript

Operator: Welcome to the Fate Therapeutics Third Quarter 2023 Financial Results Conference Call. At this time, all participants are mode.

Scott wolchkoEd dulacMichael yeeDaina grayboschAshiq mubarackYigal nochomovitzTyler van burenBob valamehrMemorial sloan kettering cancer centerFate therapeutics incProtocol design committee of lupus therapeuticsSociety for immunotherapy of cancer annual meetingLupus research allianceDevelopment officerFate therapeuticsCall transcript november